Biotechnology Council of New Jersey, Inc.

BioSpace, BCNJ, NYBA and LILSI Launch International Marketing Campaign for Tri-State Bioscience Industry
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2
Future, Facts, and Fears on Pharmaceutical & Biotech Outsourcing, More at Annual Forum, July 11-12 in Atlantic City
Lisa Flood Joins Agile Therapeutics
Pharmos Commences Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
In Vitro and In Vivo Data Show Alfacell's ONCONASE(R) is Active Against Naive and Chemoresistant Neuroblastoma Cells
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
China Biopharma to Introduce an Immunotherapeutic Vaccine into China
PTC Therapeutics Appoints Manal Morsy, M.D., PH.D. as Vice President of Regulatory Affairs
Pharma ChemOutsourcing Conference Posts Attendee List for September Custom Synthesis Blockbuster Show in New Jersey
Transave Announces Appointment of Nicholas Gurreri as Senior Vice President of Commercial Operations and Business Development
GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
King Pharmaceuticals and Palatin Technologies Announce End-of-Phase 2 Meeting With FDA for Bremelanotide
Archi-Tech Provides Targeted Suite of Analytics & Reporting Products for Pharmaceutical Managed Care Data
Roche and Toyama Chemical Enter Licensing Agreement to Develop Potential Breakthrough Drug to Treat Rheumatoid Arthritis
Shelhigh and FDA Reach an Agreement
New Study Demonstrates Colesevelam HCl Lowers Both A1C and LDL Cholesterol in Patients With Uncontrolled Type 2 Diabetes Mellitus on Metformin-Based Regimen
Barr Receives Approval for Generic VESANOID(R) Capsules, 10 mg
Leading Pharmaceutical Communication Executives Gather to Discuss Pressing Issues at the 3rd Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology Companies
Elusys Names Jeremy D. Middleton Vice President of Corporate Development
Exforge(R) Receives Final US Approval as New and Powerful Treatment Option for Patients With High Blood Pressure
Smith Praises President's Veto of Life-Destroying Embryonic Stem Cell Bill
The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bush's Veto of the Stem Cell Research Enhancement Act
inVentiv Health to Present at the Jeffries Healthcare Conference
NPS Pharmaceuticals to Webcast Presentation at Jefferies Healthcare Conference
Valeritas Completes Hiring of its Initial Diabetes Sales Leadership Team for the Launch of the h-Patch(TM) Insulin Delivery System
Vicus Therapeutics to Present Results from Investigator-led Cancer Cachexia Studies at the 12th Congress of the Japanese Society for Palliative Medicine
FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone
Bayer and Onyx Submit New European Marketing Authorization Application to EMEA for Nexavar to Treat Liver Cancer
Memory Pharmaceuticals Announces Equity Funding Led by The Stanley Medical Research Institute
Genta to Request Review of FDA Action for Genasense(R) NDA in Chronic Lymphocytic Leukemia
Image Solutions Enables Hybrid Submissions With New Version of ISIPublisher(R)
Clinsys Clinical Research, Inc. Expands Global Operations: Announces Offices Openings in Raleigh, North Carolina; Dusseldorf, Germany and Gent, Belgium
Ludlow China Upgrades China Biopharma, Inc.
Clinsys Clinical Research, Inc. Expands Global Operations: Announces Offices Openings in Raleigh, North Carolina; Dusselforf, Germany and Gent, Belgium
REMICADE(R) Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation
/C O R R E C T I O N -- Novartis Pharmaceuticals Corporation /
Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
Aegerion Pharmaceuticals Postpones Initial Public Offering
Medarex to Present at NASDAQ's 19th Investor Program Healthcare Forum
Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop
GPC Biotech to Present at Second Annual Piper Jaffray London Health Care Conference
Johnson & Johnson Invites Nominations for the 2008 Dr. Paul Janssen Award for Biomedical Research
Star Studded Pharmaceutical Competitive Intelligence & Business Analysis Conference Unveils 2007 Speaker Faculty and Agenda for October 1-2 Show in New Jersey
inVentiv Health Continues its inVentiv Pharma Forum Series with June 21 Program for Pharmaceutical Sales and Marketing Professionals
Immunomedics Set to Join Russell 3000 Index
Rosetta Genomics In-Licenses Proprietary MicroRNAs for Therapeutic use From Rockefeller University
China Biopharma Provides Guidance for Fiscal Year 2007